Masofaniten Androgen receptor-IN-2,98.28%

产品编号:Bellancom-136582| CAS NO:2416716-62-4| 分子式:C24H24Cl2N4O4S| 分子量:535.44

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-136582
4050.00 杭州 北京(现货)
Bellancom-136582
7200.00 杭州 北京(现货)
Bellancom-136582
14850.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Masofaniten Androgen receptor-IN-2

产品介绍 Masofaniten (Androgen receptor-IN-2) 是一种有效的、具有口服活性的 androgen receptor 抑制剂。Masofaniten 对前列腺癌具有抗肿瘤活性。
生物活性

Masofaniten (Androgen receptor-IN-2) is a potent and orally active androgen receptor inhibitor. Masofaniten has antitumor activity against prostate cancer.

体外研究

Masofaniten (compound A109, androgen-induced PSA-Luciferase assay) inhibits androgen binding to androgen receptor with an IC50 of 535 nM.
Masofaniten inhibits cell proliferation in LNCaP and LNCaP95 cells (IC50: 0.44 μM, 3.78 μM respectively).
Masofaniten shows a metabolic stability in liver microsome with a t1/2 of more than 120 min, and in hepatocytes with a t1/2 of more than 360 min.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Masofaniten (compound A109) (60 mg/kg, p.o.) induces partial regressions of tumor growth in NCG mice bearing LNCaP tumors.
Masofaniten (5 mg/kg, p.o., single dose, in male CD-1 mice) shows a t1/2 of 8.1 h, Cmax of 2673.3 ng/mL, F (%) of 33.6.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LNCaP Xenografts Model
Dosage: 60 mg/kg
Administration: Oral administration (p.o.)
Result: Inhibited tumor growth no obvious drug related toxicity (bodyweight change).
体内研究

Masofaniten (compound A109) (60 mg/kg, p.o.) induces partial regressions of tumor growth in NCG mice bearing LNCaP tumors.
Masofaniten (5 mg/kg, p.o., single dose, in male CD-1 mice) shows a t1/2 of 8.1 h, Cmax of 2673.3 ng/mL, F (%) of 33.6.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LNCaP Xenografts Model
Dosage: 60 mg/kg
Administration: Oral administration (p.o.)
Result: Inhibited tumor growth no obvious drug related toxicity (bodyweight change).
性状Solid
溶解性数据
In Vitro: 

DMSO : 50 mg/mL (93.38 mM; Need ultrasonic and warming)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.8676 mL 9.3381 mL 18.6762 mL
5 mM 0.3735 mL 1.8676 mL 3.7352 mL
10 mM 0.1868 mL 0.9338 mL 1.8676 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服